- Home
- GRFS vs NSIT Comparison
GRFS vs NSIT Comparison
Compare GRFS & NSIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRFS
- NSIT
- Stock Information
- Founded
- GRFS 1940
- NSIT 1988
- Country
- GRFS Spain
- NSIT United States
- Employees
- GRFS N/A
- NSIT N/A
- Industry
- GRFS Biotechnology: Pharmaceutical Preparations
- NSIT EDP Services
- Sector
- GRFS Health Care
- NSIT Technology
- Exchange
- GRFS Nasdaq
- NSIT Nasdaq
- Market Cap
- GRFS 5.1B
- NSIT 5.5B
- IPO Year
- GRFS 2006
- NSIT 1995
- Fundamental
- Price
- GRFS $7.72
- NSIT $151.01
- Analyst Decision
- GRFS Strong Sell
- NSIT Buy
- Analyst Count
- GRFS 1
- NSIT 4
- Target Price
- GRFS N/A
- NSIT $212.50
- AVG Volume (30 Days)
- GRFS 1.4M
- NSIT 401.6K
- Earning Date
- GRFS 01-01-0001
- NSIT 05-01-2025
- Dividend Yield
- GRFS N/A
- NSIT N/A
- EPS Growth
- GRFS 283.33
- NSIT N/A
- EPS
- GRFS 0.24
- NSIT 6.55
- Revenue
- GRFS $7,467,006,939.00
- NSIT $8,701,698,000.00
- Revenue This Year
- GRFS $8.45
- NSIT $3.60
- Revenue Next Year
- GRFS $7.08
- NSIT $5.24
- P/E Ratio
- GRFS $38.73
- NSIT $23.08
- Revenue Growth
- GRFS 9.41
- NSIT N/A
- 52 Week Low
- GRFS $5.68
- NSIT $146.56
- 52 Week High
- GRFS $9.96
- NSIT $228.07
- Technical
- Relative Strength Index (RSI)
- GRFS 48.63
- NSIT 37.89
- Support Level
- GRFS $7.36
- NSIT $150.32
- Resistance Level
- GRFS $7.96
- NSIT $160.47
- Average True Range (ATR)
- GRFS 0.44
- NSIT 6.37
- MACD
- GRFS -0.06
- NSIT -0.23
- Stochastic Oscillator
- GRFS 39.11
- NSIT 18.82
Stock Price Comparison Chart: GRFS vs NSIT
About GRFS Grifols S.A.
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.
About NSIT Insight Enterprises Inc.
Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, governments, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital innovation, cloud/data center transformation, connected workforce, and supply chain optimization solutions and services.